We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.59%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$60.2M
(-4.9%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
14.59%
Holding
356
New
48
Increased
68
Reduced
171
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$7.51M |
| 2 |
Orion Group Holdings
ORN
|
+$7.29M |
| 3 |
ZOES
Zoe's Kitchen, Inc.
ZOES
|
+$6.6M |
| 4 |
IMPR
IMPRIVATA, INC COM
IMPR
|
+$6.35M |
| 5 |
Ardelyx
ARDX
|
+$6.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gentherm
THRM
|
+$18.6M |
| 2 |
The Greenbrier Companies
GBX
|
+$13.3M |
| 3 |
DXP Enterprises
DXPE
|
+$11.8M |
| 4 |
POWR
POWERSECURE INTL INC COM STK (DE)
POWR
|
+$8.86M |
| 5 |
AMWD
American Woodmark
AMWD
|
+$8.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.1% |
| 2 | Healthcare | 19.91% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Energy | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
101
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.26M | 0.37% |
253,200
+44,600
| +21% | +$803K |
|
|
ARGS
102
DELISTED
Argos Therapeutics, Inc.
ARGS
| $4.2M | 0.36% |
26,125
+235
| +0.9% | +$38.9K |
|
103
Orion Energy Systems
OESX
$73.3M
| $4.16M | 0.36% |
102,268
+7,014
| +7% | +$344K |
|
|
UCTT
104
Ultra Clean Holdings
UCTT
$3.83B
| $4.11M | 0.35% |
454,500
+10,000
| +2% | +$95.6K |
|
|
ADMS
105
DELISTED
Adamas Pharmaceuticals
ADMS
| $4.11M | 0.35% |
+225,000
| New | +$4.03M |
|
|
SPNS
106
DELISTED
Sapiens International
SPNS
| $4.05M | 0.35% |
506,000
+7,300
| +1% | +$57.2K |
|
107
Nuwellis
NUWE
$627K
| – | – |
0
| – | – |
|
|
SGYP
108
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $3.86M | 0.33% |
948,500
-1,500
| -0.2% | -$6.37K |
|
109
LSI Industries
LYTS
$921M
| $3.81M | 0.33% |
477,323
+5,299
| +1% | +$41.8K |
|
110
Talphera
TLPH
$72.1M
| $3.76M | 0.32% |
18,360
| – | – |
|
|
WNS
111
DELISTED
WNS Holdings
WNS
| $3.69M | 0.32% |
192,600
| – | – |
|
112
Commercial Vehicle Group
CVGI
$152M
| $3.68M | 0.32% |
366,600
+6,600
| +2% | +$62.7K |
|
113
Avient
AVNT
$3.95B
| $3.58M | 0.31% |
84,891
+16,783
| +25% | +$657K |
|
114
Vince Holding Corp
VNCE
$91.9M
| $3.48M | 0.3% |
+9,500
| New | +$2.75M |
|
|
MDSO
115
DELISTED
Medidata Solutions, Inc.
MDSO
| $3.38M | 0.29% |
78,876
-7,568
| -9% | -$314K |
|
116
Wabtec
WAB
$49.8B
| $3.33M | 0.29% |
40,384
-5,212
| -11% | -$402K |
|
|
WIFI
117
DELISTED
Boingo Wireless, Inc.
WIFI
| $3.31M | 0.28% |
484,700
-3,600
| -0.7% | -$23.9K |
|
|
CNCE
118
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.27M | 0.28% |
323,600
+2,400
| +0.7% | +$23.2K |
|
|
SWFT
119
DELISTED
Swift Transportation Company
SWFT
| $3.26M | 0.28% |
129,324
-13,690
| -10% | -$332K |
|
120
Penske Automotive Group
PAG
$14.2B
| $3.25M | 0.28% |
65,711
-7,560
| -10% | -$345K |
|
|
XLRN
121
DELISTED
Acceleron Pharma
XLRN
| $3.16M | 0.27% |
93,100
+300
| +0.3% | +$10K |
|
122
Universal Logistics Holdings
ULH
$474M
| $3.09M | 0.27% |
122,000
| – | – |
|
|
CTP
123
DELISTED
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
| $3.04M | 0.26% |
325,200
| – | – |
|
124
Verastem
VSTM
$523M
| $3.01M | 0.26% |
27,700
+192
| +0.7% | +$20.9K |
|
125
Asbury Automotive
ABG
$3.96B
| $2.99M | 0.26% |
43,488
-4,200
| -9% | -$259K |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Wall Street Associates held 356 positions worth $1.16B, down 4.9% from $1.22B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wall Street Associates's Q2 2014 filing shows 48 new, 68 increased, 171 reduced and 42 closed positions. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 122,500 shares worth $11M. The largest sale was Gentherm, an estimated $18.6M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Wall Street Associates's largest Q2 2014 buy was Pernix Therapeutics Holdings, Inc.: 122,500 shares worth $11M.
- Wall Street Associates added most to Orion Group Holdings in Q2 2014, an estimated $7.29M increase.
- Wall Street Associates's biggest Q2 2014 reduction was The Greenbrier Companies, cutting an estimated $13.3M.
- Wall Street Associates fully exited Gentherm in Q2 2014, selling an estimated $18.6M.
- Wall Street Associates's ten largest holdings make up 15% of its $1.16B portfolio in Q2 2014.
- Wall Street Associates opened 48 new positions and closed 42 in Q2 2014.
- Wall Street Associates's portfolio value fell 4.9% quarter-over-quarter to $1.16B.
Based on Wall Street Associates's 13F filing for Q2 2014, filed 14 Aug 2014.